Document Detail

Efficacy and safety of low molecular weight heparin, unfractionated heparin and warfarin for thrombo-embolism prophylaxis in orthopaedic surgery: a meta-analysis of randomised clinical trials.
MedLine Citation:
PMID:  9212355     Owner:  NLM     Status:  MEDLINE    
CONCLUSION: in orthopaedic surgery, LMWH is significantly superior to both UFH and warfarin in the prevention of DVT and results in significantly less minor bleeding complications when compared to UFH, but significantly more minor bleeding when compared to warfarin.
A J Palmer; K Koppenhagen; B Kirchhof; U Weber; R Bergemann
Related Documents :
9989735 - Deep-vein thrombosis.
10876215 - The relationship between the number, competence, and diameter of medial calf perforatin...
1396785 - Duplex ultrasound diagnosis of symptomatic proximal deep vein thrombosis of lower limbs.
16043785 - The spectrum of presentations of venous infarction caused by deep cerebral vein thrombo...
16235015 - Temporary pulmonary vein stenosis during intraoperative transesophageal echocardiograph...
12357135 - Dietary modulations in the prevention of coronary artery disease: a special emphasis on...
Publication Detail:
Type:  Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Haemostasis     Volume:  27     ISSN:  0301-0147     ISO Abbreviation:  Haemostasis     Publication Date:    1997 Mar-Apr
Date Detail:
Created Date:  1997-09-02     Completed Date:  1997-09-02     Revised Date:  2014-07-29    
Medline Journal Info:
Nlm Unique ID:  0371574     Medline TA:  Haemostasis     Country:  SWITZERLAND    
Other Details:
Languages:  eng     Pagination:  75-84     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anticoagulants / adverse effects,  therapeutic use*
Hemorrhage / chemically induced
Heparin / adverse effects,  therapeutic use*
Heparin, Low-Molecular-Weight / adverse effects,  therapeutic use*
Postoperative Complications / prevention & control*
Randomized Controlled Trials as Topic
Thromboembolism / prevention & control*
Warfarin / adverse effects,  therapeutic use*
Reg. No./Substance:
0/Anticoagulants; 0/Heparin, Low-Molecular-Weight; 5Q7ZVV76EI/Warfarin; 9005-49-6/Heparin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Low molecular weight heparin and unfractionated heparin for prevention of thrombo-embolism in genera...
Next Document:  Effect of dermatan sulphate on activated partial thromboplastin time determined with different reage...